{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:47:04Z","timestamp":1786718824137,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijo.ijo_1288_18","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:50:43Z","timestamp":1548377443000},"page":"285","source":"Crossref","is-referenced-by-count":5,"title":["Uncontrolled neovascular glaucoma \u2013 an alarming manifestation of chronic myeloid leukemia on imatinib therapy \u2013 a case report and review of literature"],"prefix":"10.4103","volume":"67","author":[{"given":"Dewang","family":"Angmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakhyat","family":"Roop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnkitS","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.250660-1","first-page":"641","volume-title":"Ophthalmic manifestations of childhood leukaemia","author":"Rennie","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.250660-2","first-page":"663","volume-title":"Ophthalmic manifestations of acute leukaemias: The ophthalmologist's role","author":"Sharma","year":"2004","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.250660-3","first-page":"1022","volume-title":"Ocular side effects in chronic myeloid leukemia patients treated with imatinib","author":"Breccia","year":"2008","journal-title":"Leuk Res"},{"key":"key-10.4103\/0301-4738.250660-4","first-page":"371","volume-title":"Ocular side effects associated with Imatinibmesylate (Gleevec)","author":"Fraunfelder","year":"2003","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/0301-4738.250660-5","first-page":"210","volume-title":"Chronic myeloid leukemia diagnosed in a patient with uncontrolled proliferative diabetic retinopathy","author":"Figueiredo","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"key-10.4103\/0301-4738.250660-6","first-page":"1375","volume-title":"Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(\u00ae)) in a patient being treated for gastrointestinal stromal tumor (GIST)","author":"Gulati","year":"2012","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0301-4738.250660-7","first-page":"119","volume-title":"Bilateral visual loss in a patient with chronic myelogenous leukemia after initiation of imatinib therapy","author":"El","year":"2013","journal-title":"J Leuk (Los Angel)"},{"key":"key-10.4103\/0301-4738.250660-8","first-page":"659","volume-title":"Retinal capillary pericyte apoptosis in early human diabetic retinopathy","author":"Li","year":"1997","journal-title":"Chin Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0366-6999","issn-type":"print"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:40:13Z","timestamp":1786714813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1288_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["250660"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1288_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}